The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA's Division of Drug Information has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.
- FDA Drug Safety Podcast: FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density
- FDA Drug Safety Podcast: FDA modifies monitoring for neutropenia associated with schizophrenia medicine clozapine; approves new shared REMS program for all clozapine medicines
- FDA Drug Safety Podcast: FDA evaluating the risks of using the pain medicine tramadol in children aged 17 and younger
- FDA Drug Safety Podcast: FDA cautions about dose confusion and medication error with antibacterial drug Avycaz (ceftazidime and avibactam)
No hay comentarios:
Publicar un comentario